Consequences of emergency contraceptives: the adverse effects

Bibliography

• Singh Susheela WD, Hussain R, Bankole A, Sedgh G. Abortion worldwide: a decade of uneven progress. Guttmacher Institute, New York; 2009
   Google Scholar
• Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011;84(5):478-85
   PubMed Web of Science ®Google Scholar
• Jones RK, Darroch JE, Henshaw SK. Contraceptive use among U.S. women having abortions in 2000 – 2001. Perspect Sex Reprod Health 2002;34(6):294-303
   PubMed Web of Science ®Google Scholar
• Moreau C, Lydie N, Warszawski J, Bajos N. Activité sexuelle, infections sexuellement transmissibles, contraception. Baromètre Santé 2005 ed INPES 2008 2008
   Google Scholar
• Inspection générale des affaires sociales AC, Jourdain-Menninger J, Chambaud L. Evaluation des politiques de prévention des grossesses non désirées et de prise en charge des interruptions volontaires de grossesses suite à la loi du 4 juillet 2011. La documentation française, Paris; 2009
   Google Scholar
• Foundation KF. Women’s health care providers experiences with emergency contraception. 2003. Available from: wwwkfforg/womenshealth/3343-indexcfm [Accessed 12 November 2010]
   Google Scholar
• Solidarités MdlSed. Suivi du dispositif relatif à l’accès des mineures à la contraception d’urgence. Septembre 2003 — août 2004
   Google Scholar
• Faculty of Sexual & Reproductive Healthcare. Faculty of Sexual & Reproductive Healthcare clinical guidance: emergency contraception. 2011. cited 2014 January. Available from: http://www.fsrh.org/pdfs/CEUguidanceEmergencyContraception11.pdf [Last accessed 24 April 2014]
   Google Scholar
• Trussell J, Ellertson C, Stewart F. The effectiveness of the Yuzpe regimen of emergency contraception. Fam Plann Perspect 1996;28(2):58-64; 87
   PubMedGoogle Scholar
• Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Task Force on Postovulatory Methods of Fertility Regulation. Lancet 1998;352(9126):428-33
   PubMed Web of Science ®Google Scholar
• Raymond EG, Creinin MD, Barnhart KT, et al. Meclizine for prevention of nausea associated with use of emergency contraceptive pills: a randomized trial. Obstet Gynecol 2000;95(2):271-7
   PubMed Web of Science ®Google Scholar
• Rodriguez MI, Godfrey EM, Warden M, Curtis KM. Prevention and management of nausea and vomiting with emergency contraception: a systematic review. Contraception 2013;87(5):583-9
   PubMed Web of Science ®Google Scholar
• Glasier A. Emergency postcoital contraception. N Engl J Med 1997;337(15):1058-64
   PubMed Web of Science ®Google Scholar
• Lidegaard O, Milsom I, Geirsson RT, Skjeldestad FE. Hormonal contraception and venous thromboembolism. Acta Obstet Gynecol Scand 2012;91(7):769-78
   PubMed Web of Science ®Google Scholar
• Eichinger S, Evers JL, Glasier A, et al. Venous thromboembolism in women: a specific reproductive health risk. Hum Reprod Update 2013;19(5):471-82
   PubMed Web of Science ®Google Scholar
• Cheng L, Che Y, Gulmezoglu AM. Interventions for emergency contraception. Cochrane Database Syst Rev 2012;8:CD001324
   PubMed Web of Science ®Google Scholar
• von Hertzen H, Piaggio G, Ding J, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002;360(9348):1803-10
   PubMed Web of Science ®Google Scholar
• Bajos N, Leridon H, Goulard H, et al. Contraception: from accessibility to efficiency. Hum Reprod 2003;18(5):994-9
   PubMed Web of Science ®Google Scholar
• Brahmi DKN. Advance provision of emergency contraception for pregnancy prevention: RHL commentary. The WHO Reproductive Health Library, World Health Organization; Geneva: 2010
   Google Scholar
• HAS. Contraception d’urgence: prescription et délivrance à l’avance Recommandations en santé publique avril 2013
   Google Scholar
• Piaggio G, von Hertzen H, Grimes DA, Van Look PF. Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Task Force on Postovulatory Methods of Fertility Regulation. Lancet 1999;353(9154):721
   PubMed Web of Science ®Google Scholar
• Sanchez-Borrego R, Balasch J. Ethinyl oestradiol plus dl-norgestrel or levonorgestrel in the Yuzpe method for post-coital contraception: results of an observational study. Hum Reprod 1996;11(11):2449-53
   PubMed Web of Science ®Google Scholar
• Christin-Maitre S, Bouchard P, Spitz IM. Medical termination of pregnancy. N Engl J Med 2000;342(13):946-56
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R, Spitz IM. Pharmacological properties of mifepristone: toxicology and safety in animal and human studies. Contraception 2003;68(6):409-20
   PubMed Web of Science ®Google Scholar
• Morgan FH, Laufgraben MJ. Mifepristone for management of Cushing’s syndrome. Pharmacotherapy 2013;33(3):319-29
   PubMed Web of Science ®Google Scholar
• Wiebe E, Guilbert E, Jacot F, et al. A fatal case of Clostridium sordellii septic shock syndrome associated with medical abortion. Obstet Gynecol 2004;104(5 Pt 2):1142-4
   PubMed Web of Science ®Google Scholar
• Brache V, Cochon L, Deniaud M, Croxatto HB. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens. Contraception 2013;88(5):611-18
   PubMed Web of Science ®Google Scholar
• Croxatto H. EllaOne® ulipristal acetate: new generation in emergency contraception: mechanism of action. 8th Congress of the European Society of Gynecology; 10 – 13 September 2009; Roma, Italy
   Google Scholar
• Stratton P, Levens ED, Hartog B, et al. Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914. Fertil Steril 2010;93(6):2035-41
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Berger C, Lalitkumar PGL. Emergency contraception – mechanisms of action. Contraception 2013;87(3):300-8
   PubMed Web of Science ®Google Scholar
• Cameron S, Glasier A, Fine P, et al. EllaOne® ulipristal acetate: randomized comparative phase III study. 8th Congress of the European Society of Gynecology; 10 – 13 September 2009; Roma, Italy
   Google Scholar
• Salcedo J, Rodriguez MI, Curtis KM, Kapp N. When can a woman resume or initiate contraception after taking emergency contraceptive pills? A systematic review. Contraception 2013;87(5):602-4
   PubMed Web of Science ®Google Scholar
• Glasier AF, Cameron ST, Fine PM, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010;375(9714):555-62
   PubMed Web of Science ®Google Scholar
• Creinin MD, Schlaff W, Archer DF, et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006;108(5):1089-97
   PubMed Web of Science ®Google Scholar
• Richardson AR, Maltz FN. Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception. Clin Ther 2012;34(1):24-36
   PubMed Web of Science ®Google Scholar
• ANAES. Stratégies de choix des méthodes contraceptives chez la femme. Recommandations pour la pratique clinique 2004
   Google Scholar
• Glasier A, Cameron ST, Blithe D, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 2011;84(4):363-7
   PubMed Web of Science ®Google Scholar
• Raymond EG, Goldberg A, Trussell J, et al. Bleeding patterns after use of levonorgestrel emergency contraceptive pills. Contraception 2006;73(4):376-81
   PubMed Web of Science ®Google Scholar
• Trussell J. Bleeding after use of the levonorgestrel regimen of emergency contraception: concordance between women’s reports of their menstrual periods and an objective algorithm. Contraception 2007;75(1):32-6
   PubMed Web of Science ®Google Scholar
• Fine P, Mathe H, Ginde S, et al. Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. Obstet Gynecol 2010;115(2 Pt 1):257-63
   PubMed Web of Science ®Google Scholar
• Pohl O, Osterloh I, Gotteland JP. Effects of erythromycin at steady-state concentrations on the pharmacokinetics of ulipristal acetate. J Clin Pharm Ther 2013;38(6):512-17
   PubMed Web of Science ®Google Scholar
• Pohl O, Osterloh I, Lecomte V, Gotteland JP. Changes in gastric pH and in pharmacokinetics of ulipristal acetate - a drug-drug interaction study using the proton pump inhibitor esomeprazole. Int J Clin Pharmacol Ther 2013;51(1):26-33
   PubMed Web of Science ®Google Scholar
• Carten ML, Kiser JJ, Kwara A, et al. Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz. Infect Dis Obstet Gynecol 2012;2012:137192
   PubMedGoogle Scholar
• Lippes J, Malik T, Tatum HJ. The postcoital copper-T. Adv Plan Parent 1976;11(1):24-9
   PubMedGoogle Scholar
• Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital Health Stat 23 2010(29):1-44
   Google Scholar
• Baird AS. Use of ulipristal acetate, levonorgestrel and the copper-intrauterine device for emergency contraception following the introduction of new FSRH guidelines. J Fam Plann Reprod Health Care 2013;39(4):264-9
   PubMed Web of Science ®Google Scholar
• Lader D. Opinions Survey Report No.41 Contraception and Sexual Health. Newport: Office for National Statistics; 2009 2008/09
   Google Scholar
• ACOG Committee Opinion Number 542: access to emergency contraception. Obstet Gynecol 2012;120(5):1250-3
   PubMedGoogle Scholar
• Peterson HB, Curtis KM, Jamieson D, et al. US medical eligibility criteria for contraceptive use, 2010. MMWR Recomm Rep 2010;59(RR-4):1-86
   Google Scholar
• Health Care FoSR. Emergency Contraception. Clinical Effectiveness Unit. Available from: http://wwwfsrhorg/pdfs/CEUguidanceEmergencyContraception11pdf [Last accessed 12 January 2013]; August 2011, updated January 2012
   Google Scholar
• Turok DK, Godfrey EM, Wojdyla D, et al. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle. Hum Reprod 2013;28(10):2672-6
   PubMed Web of Science ®Google Scholar
• Black KI. Developments and challenges in emergency contraception. Best Pract Res Clin Obstet Gynaecol 2009;23(2):221-31
   PubMed Web of Science ®Google Scholar
• Cleland K, Zhu H, Goldstuck N, et al. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod 2012;27(7):1994-2000
   PubMed Web of Science ®Google Scholar
• Wu S, Godfrey EM, Wojdyla D, et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG 2010;117(10):1205-10
   PubMed Web of Science ®Google Scholar
• Zhou L, Xiao B. Emergency contraception with Multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception 2001;64(2):107-12
   PubMed Web of Science ®Google Scholar
• Reuter S. Barriers to the use of IUDs as emergency contraception. Br J Fam Plann 1999;25(2):61-8
   PubMedGoogle Scholar
• National Institute for Health and Clinical Excellence: Guidance. Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception. RCOG Press, London; 2005
   Google Scholar
• Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Contraception 2006;73(2):145-53
   PubMed Web of Science ®Google Scholar
• Workowski KA, Berman SM. Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis 2007;44(Suppl 3):S73-6
   PubMedGoogle Scholar
• Grimes DA, Schulz KF. Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. Contraception 1999;60(2):57-63
   PubMed Web of Science ®Google Scholar
• Glasier A. Emergency contraception: clinical outcomes. Contraception 2013;87(3):309-13
   PubMed Web of Science ®Google Scholar
• Skjeldestad FE. How effectively do copper intrauterine devices prevent ectopic pregnancy? Acta Obstet Gynecol Scand 1997;76(7):684-90
   PubMed Web of Science ®Google Scholar
• Kaneshiro B, Aeby T. Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device. Int J Women’s Health 2010;2:211-20
   PubMedGoogle Scholar
• Mishell DR Jr. Intrauterine devices: mechanisms of action, safety, and efficacy. Contraception 1998;58(3 Suppl):45S-53S; quiz 70S
   PubMed Web of Science ®Google Scholar
• Van Look PF, von Hertzen H. Emergency contraception. Br Med Bull 1993;49(1):158-70
   PubMed Web of Science ®Google Scholar
• Cleland K, Raymond E, Trussell J, et al. Ectopic pregnancy and emergency contraceptive pills: a systematic review. Obstet Gynecol 2010;115(6):1263-6
   PubMed Web of Science ®Google Scholar
• Zhang L, Chen J, Wang Y, et al. Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study. Hum Reprod 2009;24(7):1605-11
   PubMed Web of Science ®Google Scholar
• Moreau C, Trussell J, Michelot F, Bajos N. The effect of access to emergency contraceptive pills on women’s use of highly effective contraceptives: results from a French national cohort study. Am J Public Health 2009;99(3):441-2
   PubMed Web of Science ®Google Scholar
• Moreau C, Bajos N, Trussell J. The impact of pharmacy access to emergency contraceptive pills in France. Contraception 2006;73(6):602-8
   PubMed Web of Science ®Google Scholar
• Marston C, Meltzer H, Majeed A. Impact on contraceptive practice of making emergency hormonal contraception available over the counter in Great Britain: repeated cross sectional surveys. BMJ 2005;331(7511):271
   PubMed Web of Science ®Google Scholar
• Keenan JA. Ulipristal acetate: contraceptive or contragestive? Ann Pharmacother 2011;45(6):813-15
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Rabe T, Cheng L. Emergency contraception. Gynecol Endocrinol 2013;29(Suppl 1):1-14
   PubMed Web of Science ®Google Scholar
• Munuce MJ, Zumoffen C, Cicare J, et al. Effect of exposure to ulipristal acetate on sperm function. Eur J Contracept Reprod Health Care 2012;17(6):428-37
   PubMed Web of Science ®Google Scholar